Fundraising Fox

Detlev Biniszkiewicz

Investor

Managing Director at MPM BioImpact Β· Managing Director at MPM Capital

Boston, Massachusetts

FoundediTeos TherapeuticsNextPoint TherapeuticsRekindle Therapeutics

About

Managing Director and serial entrepreneur with deep expertise in oncology and immuno-oncology. Recently served as CEO of portfolio company NextPoint Therapeutics and currently chairs its Board. Previously President and CEO of Surface Oncology and held strategic roles at AstraZeneca and Novartis.

Experience

  1. MPM BioImpactManaging Director/Investment Partner - MPM Innovation Fundcurrent2020 β€” present
  2. MPM BioImpactFounder, Chairman, & Former CEO - NextPoint Therapeutics2018 β€” 2024
  3. MPM BioImpactFounder, President & CEO - Sieben Therapeutics2020 β€” 2023
  4. MPM BioImpactExecutive Partner & Serial Entrepreneur2018 β€” 2022
  5. NextPoint Therapeutics, Inc.Founder, Chairman of the Boardcurrent2022 β€” presentGreater Boston
  6. NextPoint Therapeutics, Inc.Founder, CEO, and President2018 β€” 2023Greater Boston
  7. Montis BiosciencesBoard of Directors - Independent2019 β€” 2024
  8. iTeos TherapeuticsBoard of Directors2019 β€” 2023Greater Boston
  9. 1K OncologyFounder/CEO2020 β€” 2022Greater Boston
  10. Maverick TherapeuticsBoard of Directors2018 β€” 2021San Francisco Bay Area
  11. Tilos TherapeuticsBoard of Directors - Independent2018 β€” 2020Greater Boston Area
  12. Surface Oncology Inc.Board Of Directors2015 β€” 2018
  13. Surface Oncology Inc.President & CEO2015 β€” 2017Greater Boston Area
  14. AstraZenecaVice President, Oncology - Strategy, External Science & Licensing2011 β€” 2015Greater Boston Area
  15. NovartisGlobal Head - Portfolio Management & Analysis2008 β€” 2011Greater Boston Area
  16. NovartisHead - Strategic Projects and Planning2007 β€” 2008Greater Boston Area
  17. Boston Consulting GroupPrincipal2001 β€” 2007Greater Boston Area

Education

  1. Massachusetts Institute of TechnologyPh.D. and Post-Doc Research, Genetics1996 β€” 2001

Skills & more

Biotechnology41Drug Discovery34Lifesciences12Oncology31Biopharmaceuticals12Technology Transfer6Clinical Development12Drug Development13Business Strategy1Clinical Research1Commercialization4Cross-functional Team Leadership3
+11 moreClinical TrialsCancerCell BiologyBiomarkersGeneticsGenomicsImmunologyLife SciencesStrategyPharmaceutical IndustryLeadership

From Detlev's professional profile.

Same school

Shared employers

Investments

Per SEC Form D filings.

Colleagues at MPM BioImpact

Network5

Investors connected to Detlev in public investor directories β€” a warm-intro map.